Aurora Cannabis Inc. ($ACB) Stock Forecast: Up 7.5% Today

What is Aurora Cannabis Inc.?

Aurora Cannabis (ACB) is a leading company in the cannabis industry, known for its innovative approach to genetic research and production of medical cannabis. The market for cannabis-related products has been experiencing significant growth and regulatory changes globally.

Why is Aurora Cannabis Inc. going up?

ACB stock is up 7.5% on Mar 20, 2025 16:50

• ACB's bullish movement today can be attributed to the discovery of a new source of genetic resistance against powdery mildew in cannabis sativa, showcasing the company's commitment to innovation and product development.
• The company's strategic positioning in the rapidly evolving medical cannabis landscape, with EU GMP-certified manufacturing facilities and advanced genetics, has also contributed to investor confidence and interest in ACB.
• As the global legalization wave for cannabis continues to gain momentum, ACB's strong performance and focus on developing powdery mildew-resistant plants further solidify its position as a key player in the industry, attracting potential investors seeking growth opportunities in the sector.

ACB Price Chart

ACB Technical Analysis

ACB News

What's Going On With Aurora Cannabis Shares Thursday? - Aurora Cannabis ( NASDAQ:ACB )

Aurora discovered a new source of genetic resistance against powdery mildew, a pathogen, in cannabis sativa. Given this discovery, the company is set to develop powdery mildew-resistant plants.

https://www.benzinga.com/trading-ideas/movers/25/03/44419120/whats-going-on-with-aurora-cannabis-shares-thursday

Aurora Cannabis Rides the Global Legalization Wave: Should You Invest?

ACB capitalizes on the rapidly evolving medical cannabis landscape, leveraging its EU GMP-certified manufacturing facilities, advanced genetics and deep regulatory knowledge.

https://www.zacks.com/stock/news/2431698/aurora-cannabis-rides-the-global-legalization-wave-should-you-invest

Are Medical Stocks Lagging Aurora Cannabis ( ACB ) This Year?

Here is how Aurora Cannabis Inc. (ACB) and Concentra Group (CON) have performed compared to their sector so far this year.

https://www.zacks.com/stock/news/2430795/are-medical-stocks-lagging-aurora-cannabis-acb-this-year

Trending Today

Sonic (prev. FTM) ($S) Crypto Forecast: Up 5.1% Today

Memecoin ($MEME) Crypto Forecast: Up 6.4% Today

Bonk ($BONK) Crypto Forecast: Up 10.3% Today

Jupiter ($JUP) Crypto Forecast: Up 5.1% Today

Avalanche ($AVAX) Crypto Forecast: Up 5.0% Today

Aptos ($APT) Crypto Forecast: Up 5.0% Today

Pendle ($PENDLE) Crypto Forecast: Up 5.7% Today

Toncoin ($TON) Crypto Forecast: Down 5.1% Today

Peanut Squirrel ($PNUT) Crypto Forecast: Up 5.6% Today

dogwifhat ($WIF) Crypto Forecast: Down 5.7% Today

Aurora Cannabis Inc. Price History

06.10.2024 - ACB Stock was down 17.4%

• ACB surpassed Q2 earnings and revenue expectations significantly but faced a considerable bearish trend.
• Speculations suggest that investors were anticipating even better results, prompting a sell-off post-earnings.
• Concerns may arise regarding future growth potential or market competition in the cannabis sector.
• The bearish trend could also be influenced by profit-taking or broader market sentiment rather than the company's performance.

24.09.2024 - ACB Stock was down 5.8%

• Despite launching medical cannabis oils, Aurora Cannabis (ACB) experienced a strong bearish movement.
• The market might have reacted negatively due to broader industry challenges or specific concerns about ACB's financial performance.
• Investors may have been expecting more significant growth or profitability from the new product launch, leading to disappointment and a sell-off of ACB shares.
• It's essential for traders to monitor both company-specific developments and overall industry trends to make informed decisions in the volatile cannabis market.

08.10.2024 - ACB Stock was down 5.6%

• Aurora Cannabis (ACB) reported strong quarterly earnings that exceeded market expectations, but its share price still fell by 18% due to broader sector pressures, with the cannabis sector experiencing a downturn.
• The cannabis sector as a whole took a sharp downturn after Donald Trump's presidential election victory, leading to major players like Aurora Cannabis seeing double-digit declines in their stock prices.
• Despite beating Q2 earnings and revenue estimates, Aurora Cannabis (ACB) still faced a bearish market movement, possibly due to overall sector pressures and external factors like political events impacting the industry.

25.01.2025 - ACB Stock was down 5.3%

• Analysts foresee a 25.67% upside in ACB stock, potentially influencing bullish sentiment among investors.
• Market response may have been bearish given the disparity between analyst projections and the company's actual performance.
• Investor caution regarding industry volatility and regulatory uncertainties could be weighing negatively on ACB's stock.
• The gap between analyst optimism and market performance may have prompted profit-taking and a bearish trend in ACB stock.

05.01.2025 - ACB Stock was up 44.5%

• Aurora Cannabis (ACB) experienced a strong bullish movement today.
• The surge in ACB stock price can be attributed to the company's impressive Q3 earnings report, with record-breaking net revenue of CA$88.2M.
• The significant increase in adjusted EBITDA by 316% to CA$23.1M and improved gross margin of 65% showcase the company's operational efficiency and cost management strategies.
• The positive market response indicates investor confidence in Aurora Cannabis's financial performance and growth prospects, driving the bullish movement in the stock price.

05.01.2025 - ACB Stock was up 47.6%

• Aurora Cannabis (ACB) stock surged by 45% following the release of its Q3 earnings report, which showcased record medical cannabis sales and significant growth in net revenue.
• The strong financial performance, including a 316% increase in adjusted EBITDA and improved gross margin, contributed to the bullish sentiment surrounding ACB stock.
• Additionally, the delay in U.S. tariffs on Canadian imports further boosted the cannabis sector, leading to positive market movement for Aurora Cannabis and other companies like Canopy Growth (CGC), Tilray (TLRY), and Cronos (CRON).

29.09.2024 - ACB Stock was up 5.1%

• Aurora Cannabis (ACB) exhibited a notable bullish movement today, aligning with the positive trend observed in the cannabis sector.
• The upswing in cannabis stocks could be linked to signs of recovery within the industry, leading investors to regain trust in companies like ACB.
• Favorable sentiment and heightened investor attention in the cannabis market may have played a role in the upward trajectory of Aurora Cannabis' stock price.
• The overall market dynamics indicate that ACB is capitalizing on the positive momentum in the cannabis sector, as seen through the gains in other major players like Canopy Growth (CGC) and OrganiGram Holdings (OGI).

20.02.2025 - ACB Stock was up 6.0%

• The bullish movement in ACB's stock today is possibly linked to the favorable sentiment surrounding the global legalization of cannabis, positioning the company well to benefit from this trend.
• A comparison with Concentra Group suggests that ACB is excelling within the medical stocks sector, potentially enhancing investor confidence in the stock.
• ACB's extensive regulatory expertise and robust manufacturing capabilities likely played a part in its strong performance, attracting investors interested in the expanding medical cannabis market.

20.02.2025 - ACB Stock was up 7.5%

• ACB's bullish movement today can be attributed to the discovery of a new source of genetic resistance against powdery mildew in cannabis sativa, showcasing the company's commitment to innovation and product development.
• The company's strategic positioning in the rapidly evolving medical cannabis landscape, with EU GMP-certified manufacturing facilities and advanced genetics, has also contributed to investor confidence and interest in ACB.
• As the global legalization wave for cannabis continues to gain momentum, ACB's strong performance and focus on developing powdery mildew-resistant plants further solidify its position as a key player in the industry, attracting potential investors seeking growth opportunities in the sector.

10.01.2025 - ACB Stock was up 7.4%

• Aurora Cannabis (ACB) stock saw a remarkable 45% increase following its strong performance in Q3. The report highlighted impressive medical cannabis sales and robust financial results.
• Surpassing analyst expectations by 50% in earnings and 9.50% in revenue, the company's earnings report instilled confidence in investors, propelling the stock price upwards.
• Positive market sentiment within the cannabis industry was reinforced by a recent development involving a delay in U.S. tariffs on Canadian goods, further elevating ACB's success.
• Aurora's strategic focus on efficiency, cost-cutting measures, and heightened gross margins also significantly influenced the market's positive response, hinting at a potential resurgence for the company in the competitive cannabis market.

27.01.2025 - ACB Stock was down 5.9%

• The decline in ACB stock today may be due to investors taking profits following a period of gains.
• Analysts have a positive outlook on ACB's future performance, estimating a potential upside of 25.67% according to Wall Street projections.
• The discrepancy between the stock's decline and analysts' optimistic forecasts suggests short-term market trends rather than lingering concerns over the company's prospects.
• Given the volatility of the cannabis industry, investors are advised to monitor regulatory updates and market shifts when considering investments in ACB stock.

17.02.2025 - ACB Stock was up 5.3%

• ACB's upward movement may be linked to positive internal developments like robust financial results and strategic collaborations.
• In comparison with Concentra Group (CON), ACB's strong performance in the medical segment could be enhancing investor sentiment towards the stock.
• The optimistic trajectory of ACB reflects the increasing confidence in the cannabis sector, leading to a rise in stock values industry-wide.